Pharmacognosy intro
Mentha x piperita L., Lamiaceae. Sterile hybrid of M. aquatica and M. spicata, propagated vegetatively. Leaves, flowering tops, and steam-distilled essential oil. USP, European Pharmacopoeia, British Pharmacopoeia, WHO monograph. Volatile fraction: menthol (35-45%), menthone (15-30%), menthyl acetate (3-10%), 1,8-cineole (3-7%), menthofuran. Non-volatile: rosmarinic acid (1.5-4.5% dry weight), luteolin, hesperidin, eriocitrin. Peppermint's pharmacology centers on a paradox: physical cooling with mental activation. Menthol is the most potent known natural agonist of TRPM8 cold-sensing channels. Trigeminal and olfactory cold receptor activation triggers brainstem arousal, producing immediate alertness. Simultaneously, menthol positively modulates GABAA receptors, creating anxiolytic and muscle relaxant effects that coexist with cognitive stimulation. This explains why peppermint calms the body while sharpening the mind. Rosmarinic acid competitively inhibits AChE, supporting memory effects beyond aroma exposure. Menthol modulates dopamine via alpha4-beta2 nicotinic receptors. Rosmarinic acid and luteolin suppress NF-kappaB and COX-2. Moss et al. (2008, n=144) found peppermint aroma significantly enhanced long-term and working memory and increased alertness. Raudenbush et al. (2009) documented reduced perceived workload alongside increased running speed and grip strength. Kennedy et al. (2018) confirmed cognitive benefits in a double-blind, placebo-controlled trial. Meamarbashi and Rajabi (2013, n=30) showed a single 50 microL dose enhanced grip force, vertical jump, and long jump. Menthol is detectable in blood within five minutes of inhalation. EEG shows increased beta-wave and decreased delta-wave activity within two to five minutes. Never apply near the face or nose of children under six (laryngospasm risk). Contraindicated in active GERD. Inhibits CYP3A4. Menthofuran is hepatotoxic at high doses.